PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | -88.9% | 294 | -83.4% | 0.00% | – |
| Q3 2019 | $9,000 | -10.0% | 1,772 | -1.5% | 0.00% | – |
| Q2 2019 | $10,000 | +25.0% | 1,799 | -1.3% | 0.00% | – |
| Q1 2019 | $8,000 | 0.0% | 1,823 | -0.3% | 0.00% | – |
| Q4 2018 | $8,000 | -38.5% | 1,828 | -8.1% | 0.00% | – |
| Q3 2018 | $13,000 | -31.6% | 1,990 | -18.1% | 0.00% | – |
| Q2 2018 | $19,000 | 0.0% | 2,430 | 0.0% | 0.00% | – |
| Q1 2018 | $19,000 | +11.8% | 2,430 | -8.2% | 0.00% | – |
| Q4 2017 | $17,000 | 0.0% | 2,646 | +20.0% | 0.00% | – |
| Q3 2017 | $17,000 | 0.0% | 2,205 | -9.1% | 0.00% | – |
| Q2 2017 | $17,000 | -79.5% | 2,426 | -72.4% | 0.00% | -100.0% |
| Q1 2017 | $83,000 | +9.2% | 8,780 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $76,000 | +216.7% | 8,780 | +134.2% | 0.00% | – |
| Q3 2016 | $24,000 | +100.0% | 3,749 | +33.0% | 0.00% | – |
| Q2 2016 | $12,000 | +500.0% | 2,819 | +493.5% | 0.00% | – |
| Q1 2016 | $2,000 | -33.3% | 475 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | 0.0% | 475 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | -62.5% | 475 | -59.6% | 0.00% | – |
| Q2 2015 | $8,000 | +60.0% | 1,175 | +46.9% | 0.00% | – |
| Q1 2015 | $5,000 | -16.7% | 800 | 0.0% | 0.00% | – |
| Q4 2014 | $6,000 | +100.0% | 800 | +44.4% | 0.00% | – |
| Q3 2014 | $3,000 | – | 554 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|